| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043114A1 Use of serum/plasma microrna in early diagnosis of hbv infection and liver cancer |
| 04/22/2010 | WO2010043057A1 Bsa-specific antibodies |
| 04/22/2010 | WO2010043047A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | WO2010042974A1 Hybrid plant cell |
| 04/22/2010 | WO2010025395A3 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/22/2010 | WO2010017562A3 Induced pluripotent stem cells |
| 04/22/2010 | WO2010012760A3 Plants having modified growth characteristics and a method for making the same |
| 04/22/2010 | WO2010011960A3 Triple acting antimicrobials that are refractory to resistance development |
| 04/22/2010 | WO2010011769A3 Systems and methods for selective alcohol production |
| 04/22/2010 | WO2010005722A3 Methods and compositions for generating sporulation deficient bacteria |
| 04/22/2010 | WO2010005227A3 Recombinant expression vector for animal cell |
| 04/22/2010 | WO2010003766A3 Multimeric tnf receptors |
| 04/22/2010 | WO2010002939A3 Methods for real time single molecule sequencing |
| 04/22/2010 | WO2010000708A3 Promoters from brassica napus for seed specific gene expression |
| 04/22/2010 | WO2009158618A3 Avian reoviridae |
| 04/22/2010 | WO2009158040A3 Cancer platinum resistance detection and sensitization method |
| 04/22/2010 | WO2009155723A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 04/22/2010 | WO2009149419A3 Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
| 04/22/2010 | WO2009147271A3 System for packaging high-capacity adenoviruses |
| 04/22/2010 | WO2009145820A3 Generation of modified polymerases for improved accuracy in single molecule sequencing |
| 04/22/2010 | WO2009143397A3 Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
| 04/22/2010 | WO2009137660A3 Enhancement of drug therapy by mirna |
| 04/22/2010 | WO2009131710A3 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof |
| 04/22/2010 | WO2009100102A3 Ts23 alpha-amylase variants with altered properties |
| 04/22/2010 | WO2009029601A3 Receptor-targeting reagents |
| 04/22/2010 | WO2007022403A3 Ocular gene therapy using avalanche-mediated transfection |
| 04/22/2010 | US20100100986 Promoter for the high level expression in plant-tissue culture and vector using the same |
| 04/22/2010 | US20100100985 Methods and Compositions for Increasing the Nitrogen Storage Capacity of a Plant |
| 04/22/2010 | US20100100984 Transgenic Plants Exhibiting Increased Resistance to Biotic and Abiotic Stresses or Accelerated Flowering Time and Methods for Producing the Same |
| 04/22/2010 | US20100100982 Preparation of Organisms with Faster Growth and/Or Higher Yield |
| 04/22/2010 | US20100100981 Wuschel (wus) gene homologs |
| 04/22/2010 | US20100100980 Methods and Compositions to Enhance Plant Breeding |
| 04/22/2010 | US20100100979 Biomarker specific for cancer |
| 04/22/2010 | US20100100977 Probe for visualizing cell-cycle |
| 04/22/2010 | US20100100976 Methods and compositions related to apobec-1 expression |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100100974 Models of Malignant Brain Cancer, and Therapeutic siRNAs Against Oncogenic Signaling Pathways, and Methods and Kits for Uses Therefor |
| 04/22/2010 | US20100099900 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
| 04/22/2010 | US20100099855 Recombinant protein comprising starch binding domain and use thereof |
| 04/22/2010 | US20100099853 Multivalent Antibody Constructs |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100099750 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease |
| 04/22/2010 | US20100099748 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 04/22/2010 | US20100099746 Novel nucleic acid |
| 04/22/2010 | US20100099745 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/22/2010 | US20100099741 Molecular Targets for Treatment of Learning and Memory Dysfunction |
| 04/22/2010 | US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/22/2010 | US20100099739 Compositions and Methods for Gene Silencing |
| 04/22/2010 | US20100099627 Nuclear targeting sequences |
| 04/22/2010 | US20100099610 Transglutaminase Variants with Improved Specificity |
| 04/22/2010 | US20100099601 Fibrillation-resistant insulin and insulin analogues |
| 04/22/2010 | US20100099598 Amylase Variants |
| 04/22/2010 | US20100099597 Amylase Variants |
| 04/22/2010 | US20100099578 siRNA Targeting Fructose-1, 6-bisphosphatase 1 (FBP1) |
| 04/22/2010 | US20100099191 Rna interference tags |
| 04/22/2010 | US20100099184 Polynucleotides encoding class ii cytokine receptor-7 |
| 04/22/2010 | US20100099182 System for monitoring the location of transgenes |
| 04/22/2010 | US20100099168 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex |
| 04/22/2010 | US20100099167 for producing beta-alanine, pantothenate, 3-hydroxypropionic acid, as well as other organic compounds |
| 04/22/2010 | US20100099154 Pufa polyketide synthase systems and uses thereof |
| 04/22/2010 | US20100099148 Novel Vectors for Production of Antibodies |
| 04/22/2010 | US20100099147 Anti-IGF-1R Antibodies and Uses Thereof |
| 04/22/2010 | US20100099146 Variants of Beta-Glucosidases |
| 04/22/2010 | US20100099144 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells |
| 04/22/2010 | US20100099143 Enhanced isomerases for use in production of pantothenic acid or 3-hydroxypropionic acid |
| 04/22/2010 | US20100099122 Ferric reductase activity of histoplasma capsulatum y-glutamyltransferase |
| 04/22/2010 | US20100099111 Antibodies against a protein entitled 161p2f10b |
| 04/22/2010 | US20100099108 Method for Detecting, Isolating, and Characterizing Cells from Body Samples by Transfection with Nucleic Acid Constructs |
| 04/22/2010 | US20100099105 Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (bcrp) |
| 04/22/2010 | US20100099104 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 04/22/2010 | US20100099098 Methods and compositions for diagnosing and monitoring transplant rejection |
| 04/22/2010 | US20100099096 Compositions and Methods for Identifying Factors Affecting Protein Stability |
| 04/22/2010 | US20100099078 Method for designing a drug regime for hiv-infected patients |
| 04/22/2010 | US20100098807 Endoglucanase ppce and cellulase preparation containing the same |
| 04/22/2010 | US20100098737 methods and compositions for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
| 04/22/2010 | US20100098722 Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use |
| 04/22/2010 | US20100098719 Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G |
| 04/22/2010 | US20100098718 Nucleic acid vectors for immunization |
| 04/22/2010 | US20100098717 Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof |
| 04/22/2010 | US20100098715 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098706 Monoclonal antibody directed against the human ldl receptor |
| 04/22/2010 | US20100098704 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098695 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098666 Humanized Viral Vectors and Methods of Use Thereof |
| 04/22/2010 | US20100098663 Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA |
| 04/22/2010 | US20100098635 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses |
| 04/22/2010 | US20100098625 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/22/2010 | US20100096548 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 04/22/2010 | DE112008001277T5 Transgene Pflanzen mit erhöhter Stresstoleranz und erhöhtem Ertrag Transgenic plants with increased stress tolerance and increased yield |
| 04/22/2010 | DE102008052529A1 Expressionsverstärkte Nukleinsäuren Increased expression of nucleic acids |
| 04/22/2010 | DE102008045705A1 Verfahren zur Gewinnung von kurzer RNA sowie Kit hierfür A process for the production of short RNA and kit therefor |
| 04/22/2010 | CA2777486A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | CA2740785A1 Modulation of factor 11 expression |
| 04/22/2010 | CA2740561A1 Bsa-specific antibodies |